JackTStapletonMD

Grant Support

• Characterization Of Cell GBV-C Envelope Glycoprotein InteractionsVeterans Affairs2011–2012
• GBV-C Effects On CD4 Activation And ExpansionNational Institute Of Allergy And Infectious Diseases2009–2011
• Research Training In Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2004–2011
• GB Virus Type C Natural History, Epidemiology, HIV InteractionNational Institute Of Allergy And Infectious Diseases2007–2008
• Smallpox Vaccination On Endothelial Function And Human Gene ExpressionNational Center For Research Resources2005–2006
• GBV-C Natural History, Epidemiology, HIV InteractionNational Institute Of Allergy And Infectious Diseases2004–2006
• Effect Of GB Virus C Infection On HIV Infection, CD4 Cell Counts And HIV RNANational Center For Research Resources2005
• Effects Of Statins On Hepatitis C And GBV-C Viral LoadsNational Center For Research Resources2004–2005
• Smallpox Vaccination On Endothelial FunctionNational Center For Research Resources2004
• Informed Consent To Use Stored Human Biological MaterialsNational Center For Research Resources2004
• Aventis Pasteur'S Smallpox Vaccine In Vaccinia-NaiveNational Center For Research Resources2004
• ACTG A5088 Interleukin-2 And Pegylated InterferonNational Center For Research Resources2004
• Clinical Evaluation Of Echinacea And Hypericum In HIV-1 Infected SubjectsNational Institute Of Environmental Health Sciences2002
• Trial Of IV Wf10 (TCDO) In Patients With LATE Stage HIV DiseaseNational Center For Research Resources2000–2002
• Treatment Rollover For PTS Formerly On ACTG 328: IL-2National Center For Research Resources2000–2002
• ACTG 5025 Hydroxyurea And Potent Antiretroviral TherapyNational Center For Research Resources2000–2002
• ACTG 388 Trial Of Efz Or Nfv With Lamivudine/Zdv &Indinavir In HIV InfectionNational Center For Research Resources2000–2002
• Triple Combination Drug Therapy For HIV 1 SubjectsNational Center For Research Resources1999–2002
• ACTG 398 Amprenavir As PART Of Dual Protease Inhibitor Regimens In HIVNational Center For Research Resources1999–2002
• ACTG 384, Protease &Non Nucleoside Reverse Transcriptase Inhibitor For HIVNational Center For Research Resources1999–2002
• ACTG 372--Virologic Success Of Indinavir With Nucleoside Analogs In HIVNational Center For Research Resources1998–2002
• ACTG 368--159u89 With Indivavir Sulfate And Dmp266 In HIV SubjectsNational Center For Research Resources1998–2002
• ACTG 343--Three Maintenance Regimens For HIV Infected SubjectsNational Center For Research Resources1998–2002
• ACTG 328--Recombinant Human Interleukin 2 In Subjects With HIVNational Center For Research Resources1998–2002
• Evaluation Of GB Virus C Replication And HIV InhibitionNational Institute Of Allergy And Infectious Diseases2001
• Hcv-Alcohol Interactions-- Pathogenesis And EpidemiologyNational Institute On Alcohol Abuse And Alcoholism2000–2001
• Effects Of Alcohol On HIV ReplicationNational Center For Research Resources1998–2000
• Delavirdine Mesylate With Zidovudine VS ZDV Alone In HIV1 SubjectsNational Center For Research Resources1998–2000
• Nevirapine, Lamivudine And Background Nucleoside Therapy In AIDSNational Center For Research Resources1997–2000
• Hepatitis C Virus-Alcohol Interactions-- Pathogenesis AnNational Institute On Alcohol Abuse And Alcoholism1999
• Delavirdine Mesylate With Didanosine VS DDI Alone In HIV1 SubjectsNational Center For Research Resources1998–1999
• Dapsone And Atovaquone For Prophylaxis Against PCP In HIV Infected PatientsNational Center For Research Resources1998–1999
• Asymptomatic Patients On Zidovudine Monotherapy In HIV PatientsNational Center For Research Resources1998–1999
• ACTG 320--Indinavir With Zidovudine And Lamivudine In HIV InfectionNational Center For Research Resources1998–1999
• Delavirdine Mesylate Treatment In Triple Combination For HIV PatientsNational Center For Research Resources1996–1999
• Delavirdine Mesylate With Zidovudine VS ZDV Alone In HIV 1 SubjectsNational Center For Research Resources1997
• Actg--Zidovudine Monotherapy In Asymptomatic HIV Positive AdultsNational Center For Research Resources1997
• Actg--Indinavir With Zidovudine And Lamivudine In HIV InfectionNational Center For Research Resources1997
• Alcohol Effects On HIV ReplicationNational Institute On Alcohol Abuse And Alcoholism1996–1997
• Didanosine And Nevirapine In HIV Positive AdultsNational Center For Research Resources1996–1997
• Delavirdine Mesylate With Didanosine VS DDI Alone In HIV 1 SubjectsNational Center For Research Resources1996–1997
• Actg--Dapsone And Atovaquone For Prophylaxis Against PCP In HIVNational Center For Research Resources1996–1997
• Valacyclovir Hydrochloride Prophylaxis For CMV Disease In HIV InfectionNational Center For Research Resources1996
• Dilavirdine Mesylate With Zidovudine VS ZDV Alone In HIV 1 SubjectsNational Center For Research Resources1996
• Clarithromycin VS Rifabutin VS Both To Prevent Mycobacterium Avium In HIV AdultsNational Center For Research Resources1996
• Actg--Zidovudine Therapy In HIV Positive AdultsNational Center For Research Resources1996
• Nucleosides As Monotherapy VS Combination In NON Hemophiliac HIV PatientsNational Center For Research Resources1993
• Immunogenicity Of An Inactivated Hepatitis A VaccineNational Center For Research Resources1993